[Daily defined doses of parkinsonian drugs in Alcoi].
Copyright policy )[Daily defined doses of parkinsonian drugs in Alcoi].
Some authors have suggested that the use of DDD (defined daily doses) of L-dopa may be useful as an indicator of the frequency of Parkinson's disease.To determine the measurement for L-dopa and selegiline in Alcoi.We have obtained the intakes for L-dopa and selegiline between January and December, 1990 and we have calculated the DDD/1,000 inhab/day.During the study period, we have found that the mean intakes were 18,000.969 mg and 53,800 mg for L-dopa and selegiline, respectively. And so, the L-dopa intake in Alcoi was 0.60 DDD/ 1,000 inh, and the selegiline intake was 0.21 DDD/1,000 inh.Comparing the other data of the literature, specially in scandinavian countries, the obtained intake for L-dopa was low, and that could indicate that the frequency of the disease in Alcoi was lower.
- University of Alicante Spain
Antiparkinson Agents, Levodopa, Dose-Response Relationship, Drug, Spain, Selegiline, Humans, Parkinson Disease, Drug Utilization
Antiparkinson Agents, Levodopa, Dose-Response Relationship, Drug, Spain, Selegiline, Humans, Parkinson Disease, Drug Utilization
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!